ARCHIVES

Sense Of Excitement, Challenges, Mark Healy’s Debut

This article is from The Cancer Letter archive.

Vol. 17 No. 17 | April 26, 1991

Download PDF Visit The Full Archive

Related Articles

Committee Recommends FDA Approval Of Three New Drugs For Cancer Treatment

March 27, 1998

Congressional News: Senate To NIH: Administrative Offices Should Consolidate

September 20, 1996

Phase II Study Of Pfizer Drug Meets Primary Endpoint

April 24, 2009

ODAC Unanimously Rejects Melblez, Citing Lower Survival

May 17, 2013

Senate Confirms McClellan For FDA

October 25, 2002

Responses So Far Support Outstanding Investigator Grant; NCAB Members Object To Salary commitment

July 8, 1983